Webinar: Transcriptomics to decipher the pathobiology of drug resistance and enable targeted therapeutics

Researching and understanding the mechanisms of drug resistance are essential to determine therapies that are more effective on an individual basis. Computational biology tools combined with transcriptome analysis allow the characterization of differential gene expression signatures in response to treatment in resistant vs. non-resistant human-derived cancer cells.

Many biomarkers including noncoding RNAs and alternatively-spliced variants have been associated with tumor pathogenesis or drug resistance. These biomarkers represent candidates to help elucidate the biology of diseases, to identify the mechanisms for drug resistance, and to design better targeted therapies for precision medicine.

In the webinar, Dr. Yesim Gökmen-Polar will describe:

  • The importance of alternative splicing and noncoding RNAs in cancer biology
  • Transcriptomics workflows using Applied Biosystems Clariom assays to identify biomarkers and drug resistance mechanisms
  • Applications in breast and thymic cancer research


Yesim Gökmen-Polar, PhD, Assistant Research Professor,
Department of Pathology and Laboratory Medicine,
Indiana University School of Medicine

Dr. Gökmen-Polar’s research focuses on the identification of novel therapeutic targets in breast and thymic cancers resistant to standard-of-care therapy. She has published approximately 50 scientific journal articles in the field of cancer biology.

For Research Use Only. Not for use in diagnostic procedures.

* Required field


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.